In vitro aerosol characterization of Staccato® Loxapine

Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices

J. Lenney, J. Alastair Innes, G K Crompton · Respiratory Medicine · 2000 · 265 citations · Full text

EPSM 2005 Workshop - IEC 60601-1: Medical Electrical Equipment - Part 1: General Requirements for Basic Safety and Essential Performance - 3rd Edition 2005

Lawrence M Knuckey · Australasian Physical & Engineering Sciences in Medicine · 2006 · 154 citations

Safety Engineering, Epsm 2005, Safety-critical System +14

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine

Michael D. Lesem, Tram Tran-Johnson, Robert Riesenberg et al. · The British Journal of Psychiatry · 2011 · 153 citations · Full text

Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 2: Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers

A DEBOER, Doetie Gjaltema, Paul Hagedoorn · International Journal of Pharmaceutics · 1996 · 88 citations

Asthma, Vitro Drug Delivery, Lung Deposition +6

<i>In-Vitro</i> Intra- and Inter-Inhaler Flow Rate-Dependent Dosage Emission from a Combination of Budesonide and Eformoterol in a Dry Powder Inhaler

Walid Tarsin, K.H. Assi, Henry Chrystyn · Journal of Aerosol Medicine · 2004 · 74 citations